Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
U.S. District Court Orders Preliminary Injunction Hearing on Xockets' Antitrust Lawsuit Against Nvidia
-
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Union: Extending the Rent Cap Is Nothing but a Stop-Gap Measure
-
Azitra to Present at the H.C. Wainwright 26th Annual Global Investment Conference
-
NEO Battery Materials Announces Closing of NBM Korea Co. Share Purchase Agreement
-
Qualigen Therapeutics, Inc. Announces Closing of $3.47 Million Public Offering
-
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
-
Iterum Therapeutics to Present at the 26th Annual H.C. Wainwright Global Investment Conference
-
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
University of Phoenix College of Doctoral Studies Releases White Paper Exploring Leadership Qualities and Implications for Organizational Workforce Health
-
New Home Build Complete in Fairview, Texas
-
Elutia Celebrates First Year
-
THE SWISS HELVETIA FUND, INC. DECLARES QUARTERLY DISTRIBUTION OF $0.129 PER SHARE
-
PennyMac Financial Services, Inc. Announces Changes to Its Board of Directors
-
ECOVACS and Its New DEEBOT X8 PRO OMNI Win Two Global Product Technology Innovation Awards at IFA 2024
-
New U.S. Production Facility: Disposable Design Launches Factory for Custom Plastic Cups, Boosting Domestic Manufacturing
-
Huntington adds corporate mortgage finance business to commercial banking
-
Fortune Rise Acquisition Corporation Receives September Monthly Extension From Sponsor Affiliate to Complete its Initial Business Combination
-
American Healthcare REIT Declares Third Quarter 2024 Distribution
-
Marathon Petroleum Corp. to Report Third-Quarter Financial Results on November 5, 2024
-
MPLX LP to Report Third-Quarter Financial Results on November 5, 2024
-
AvalonBay Communities, Inc. Announces Participation in Bank of America’s Global Real Estate Conference
-
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
TPG RE Finance Trust, Inc. Declares Cash Dividend on Series C Cumulative Redeemable Preferred Stock
-
HTD Expands Product Development to New Resources in Vietnam
-
Desert Gold Announces Early Warrant Exercise Incentive Program
-
Bruce Chinn Elected to Celanese Board of Directors
-
Pheton Holdings Ltd Announces Closing of Initial Public Offering
-
Vaxcyte Announces Closing of $1.5 Billion Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Vertex to Present at Goldman Sachs Conference
-
Relay Therapeutics Announces Webcast to Report RLY-2608 Data on September 9, 2024
-
Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Codexis Announces New Employment Inducement Grants
-
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
-
Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference
-
Freshpet, Inc. Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
-
Innovex and Dril-Quip Complete Merger, Creating Unique Energy Industrial Platform
-
Green Dot Corporation Announces Completion of $45 Million Senior Unsecured Notes Offering
-
Savara Announces New Employment Inducement Grant
-
Foresight Receives Nasdaq Notification Regarding Minimum Bid Requirements
-
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
FDA Roundup: September 6, 2024
-
CTA to Fed Parties: It’s Time to Cut Red Tape & Tax, Restore Fairness for Truckers
-
CTA to Fed Parties: It’s Time to Cut Red Tape & Tax, Restore Fairness for Truckers
-
NurExone Demonstrates Extended Therapeutic Window of ExoPTEN Post Spinal-Cord Injury in Preclinical Study
-
Innovex and Dril-Quip Complete Merger, Creating Unique Energy Industrial Platform
-
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
-
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Cansortium Announces Shares for Debt Settlement
-
HYZON ANNOUNCES 1-FOR-50 REVERSE STOCK SPLIT
